FDA Import Refusal 1FX-2443269-3/10002/2 — Glenmark Pharmaceuticals Limited
The FDA refused shipment 1FX-2443269-3/10002/2 from Glenmark Pharmaceuticals Limited (India) on Oct 8, 2026. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 8, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 27